We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow % of AUM
Cap. Flow %
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.5
years
Top 20 Avg Time Held
Equity + Options
4
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2351
Fidelity MSCI Financials Index ETF
FNCL
$2.29B
| $1.14M | ﹤0.01% |
16,280
+211
| +1% | +$15.7K |
2021 Q3
18 quarters
|
|
2352
Bruker
BRKR
$8.35B
| $1.14M | ﹤0.01% |
31,566
+15,046
| +91% | +$629K |
2022 Q4
13 quarters
|
|
2353
CG Oncology
CGON
$5.31B
| $1.14M | ﹤0.01% |
16,834
+8,669
| +106% | +$491K |
2025 Q3
2 quarters
|
|
2354
Mercury Insurance
MCY
$5.69B
| $1.14M | ﹤0.01% |
12,903
+1,500
| +13% | +$134K |
2025 Q3
2 quarters
|
|
2355
Immunovant
IMVT
$5.52B
| $1.14M | ﹤0.01% |
45,729
+4,228
| +10% | +$109K |
2024 Q4
5 quarters
|
|
2356
Booz Allen Hamilton
BAH
$8.93B
| $1.14M | ﹤0.01% |
14,553
-14,937
| -51% | -$1.26M |
2021 Q1
20 quarters
|
|
2357
Openlane
OPLN
$4.52B
| $1.13M | ﹤0.01% |
38,933
+5,399
| +16% | +$156K |
2024 Q3
6 quarters
|
|
2358
Global Industrial
GIC
$1.68B
| $1.13M | ﹤0.01% |
35,967
+2,535
| +8% | +$79.7K |
2025 Q1
4 quarters
|
|
2359
Intuitive Machines
LUNR
$1.74B
| $1.13M | ﹤0.01% |
60,913
+15,280
| +33% | +$282K |
2024 Q3
6 quarters
|
|
2360
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$3B
| $1.13M | ﹤0.01% |
60,522
+5,028
| +9% | +$94.6K |
2024 Q3
6 quarters
|
|
2361
Live Oak Bancshares
LOB
$1.62B
| $1.13M | ﹤0.01% |
34,038
-2,539
| -7% | -$93.6K |
2023 Q4
9 quarters
|
|
2362
Vanguard Long-Term Treasury ETF
VGLT
$10.7B
| $1.12M | ﹤0.01% |
20,302
+8,391
| +70% | +$471K |
2023 Q3
10 quarters
|
|
2363
Healthcare Services Group
HCSG
$1.45B
| $1.12M | ﹤0.01% |
60,533
+36,838
| +155% | +$727K |
2025 Q3
2 quarters
|
|
2364
Omnicell
OMCL
$1.61B
| $1.12M | ﹤0.01% |
33,419
+16,608
| +99% | +$695K |
2024 Q2
7 quarters
|
|
2365
Worthington Enterprises
WOR
$3.16B
| $1.11M | ﹤0.01% |
21,383
-4,700
| -18% | -$252K |
2022 Q3
14 quarters
|
|
2366
Banc of California
BANC
$2.72B
| $1.11M | ﹤0.01% |
63,325
+25,846
| +69% | +$493K |
2024 Q1
8 quarters
|
|
2367
Hope Bancorp
HOPE
$1.72B
| $1.11M | ﹤0.01% |
99,660
-6,085
| -6% | -$70.3K |
2025 Q2
3 quarters
|
|
2368
First Bancorp
FBNC
$2.5B
| $1.11M | ﹤0.01% |
19,720
+6,291
| +47% | +$359K |
2013 Q2
51 quarters
|
|
2369
First Advantage
FA
$3.29B
| $1.11M | ﹤0.01% |
94,388
+76,408
| +425% | +$934K |
2025 Q4
1 quarter
|
|
2370
Karman Holdings
KRMN
$4.6B
| $1.11M | ﹤0.01% |
13,852
+9,845
| +246% | +$949K |
2025 Q4
1 quarter
|
|
2371
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.45B
| $1.11M | ﹤0.01% |
22,014
-565
| -3% | -$28.5K |
2021 Q4
17 quarters
|
|
2372
Core & Main
CNM
$7.74B
| $1.11M | ﹤0.01% |
22,422
+12,896
| +135% | +$694K |
2024 Q4
5 quarters
|
|
2373
Tango Therapeutics
TNGX
$3.72B
| $1.11M | ﹤0.01% |
52,907
+11,000
| +26% | +$153K |
2025 Q3
2 quarters
|
|
2374
Jackson Financial
JXN
$8.84B
| $1.1M | ﹤0.01% |
10,444
-1,017
| -9% | -$114K |
2023 Q3
10 quarters
|
|
2375
Farmers National Banc Corp
FMNB
$906M
| $1.1M | ﹤0.01% |
83,802
+23,889
| +40% | +$314K |
2022 Q4
13 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.